Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Timothy M Dempsey"'
Autor:
Charles L. Sprung, Asha V. Devereaux, Marya Ghazipura, Lisa D. Burry, Tanzib Hossain, Mitchell T. Hamele, Ramon E. Gist, Timothy M. Dempsey, Jeffrey R. Dichter, Kiersten N. Henry, Alexander S. Niven, Timur Alptunaer, Meredith Huffines, Kasey R. Bowden, Anne Marie O. Martland, Jamie R. Felzer, Steven H. Mitchell, Pritish K. Tosh, Jason Persoff, Vikramjit Mukherjee, James Downar, Amado A. Báez, Ryan C. Maves
Publikováno v:
Chest.
Autor:
Nilay Shah, Xiaoxi Yao, Timothy M. Dempsey, Lindsey R. Sangaralingham, Stephanie Payne, Andrew H. Limper
Publikováno v:
Annals of the American Thoracic Society. 18:1121-1128
Rationale: In October 2014, the antifibrotic medications pirfenidone and nintedanib became the first medications approved by the U.S. Food and Drug Administration for use in patients with idiopathi...
Publikováno v:
BMC Pulmonary Medicine
BMC Pulmonary Medicine, Vol 22, Iss 1, Pp 1-8 (2022)
BMC Pulmonary Medicine, Vol 22, Iss 1, Pp 1-8 (2022)
Background The anti-fibrotic medications nintedanib and pirfenidone were approved in the United States for use in patients with idiopathic pulmonary fibrosis several years ago. While there is a growing body of evidence surrounding their clinical effe
Autor:
Andrew H. Limper, Stephanie Payne, Lindsey R. Sangaralingham, Bryan T. Kelly, Viengneesee Thao, Timothy M. Dempsey, Nilay Shah, Teng Moua, T. Teague
Publikováno v:
BMC Pulmonary Medicine, Vol 21, Iss 1, Pp 1-14 (2021)
BMC Pulmonary Medicine
BMC Pulmonary Medicine
Background Idiopathic Pulmonary Fibrosis is a chronic, progressive interstitial lung disease for which there is no cure. However, lung function decline, hospitalizations, and mortality may be reduced with the use of the antifibrotic medications, nint
Autor:
Timothy M. Dempsey, Nilay Shah, Lindsey R. Sangaralingham, Darshak Sanghavi, Xiaoxi Yao, Andrew H. Limper
Publikováno v:
American Journal of Respiratory and Critical Care Medicine. 200:168-174
Rationale: Since their approval, there has been no real-world or randomized trial evidence evaluating the effect of the antifibrotic medications pirfenidone and nintedanib on clinically important o...
Publikováno v:
Annals of the American Thoracic Society
Autor:
Timothy M. Dempsey, Andrew H. Limper
Publikováno v:
American Journal of Respiratory and Critical Care Medicine